Godavari Biorefineries Limited AI Stock Analysis
Want to see IN:GODAVARIB full AI Analyst Report?
Godavari Biorefineries Limited (GODAVARIB) AI Stock Analysis
Godavari Biorefineries Limited
(NSE:GODAVARIB)
Improving revenue, operating performance, balance-sheet strength, and operating cash flow are the main positives. These are outweighed by fragile net profitability, negative free cash flow, bearish technical conditions, and an exceptionally high P/E ratio.
Godavari Biorefineries Limited (GODAVARIB) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 11.78B
- Dividend Yield
- ―
- Average Volume (3M)
- 23.29K
- Price to Earnings (P/E)
- 39.5
- Beta (1Y)
- 1.09
- Revenue Growth
- 7.05%
- EPS Growth
- 26.42%
- Country
- India
- Employees
- 1,729
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Godavari Biorefineries Limited Business Overview & Revenue Model
Company Description
Godavari Biorefineries Limited, an Indian company established in Mumbai in 1939, specializes in the production and sale of sugar and a wide array of bio-based products. Its sugar offerings encompass classic, brown, plantation white, and refined varie...
How the Company Makes Money
Godavari Biorefineries makes money by converting sugarcane-based feedstocks into a portfolio of saleable products and selling them to industrial and consumer-ingredient customers. Key revenue streams include: (1) Bio-based specialty chemicals/ingredi...
Godavari Biorefineries Limited Financial Statement Overview
Summary
Revenue growth, improving operating margins, manageable leverage, and stronger operating cash flow support the score. However, net profitability remains fragile and free cash flow is negative.
Income Statement
62PositiveBalance Sheet
74PositiveCash Flow
55Neutral| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.13B | 18.70B | 19.88B | 16.87B | 20.15B | 17.02B |
| Gross Profit | 4.12B | 3.14B | 3.72B | 3.31B | 3.79B | 3.23B |
| EBITDA | 1.02B | 1.12B | 1.08B | 1.43B | 1.48B | 1.34B |
| Net Income | 2.25M | -234.15M | 35.28M | 122.98M | 196.37M | 190.97M |
Balance Sheet | ||||||
| Total Assets | 0 | 19.55B | 20.52B | 19.92B | 17.44B | 17.34B |
| Cash, Cash Equivalents and Short-Term Investments | 321.53M | 122.51M | 321.53M | 111.12M | 212.73M | 100.25M |
| Total Debt | 0 | 4.90B | 5.31B | 6.55B | 7.36B | 6.36B |
| Total Liabilities | -7.88B | 11.73B | 12.64B | 14.91B | 12.54B | 12.61B |
| Stockholders Equity | 7.88B | 7.82B | 7.88B | 5.01B | 4.89B | 4.73B |
Cash Flow | ||||||
| Free Cash Flow | 238.17M | -654.94M | -446.91M | 1.30B | -203.70M | -55.30M |
| Operating Cash Flow | 936.34M | 61.52M | 1.24B | 1.85B | 1.97B | 448.60M |
| Investing Cash Flow | -663.53M | -687.56M | -1.66B | -439.93M | -2.14B | -476.72M |
| Financing Cash Flow | -257.29M | 637.43M | 444.35M | -1.51B | 284.26M | 59.50M |
Godavari Biorefineries Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:GODAVARIB, the sentiment is Negative. The current price of 205.20 is below the 20-day moving average (MA) of 218.90, below the 50-day MA of 228.20, and below the 200-day MA of 269.54, indicating a bearish trend. The MACD of -1.33 indicates Negative momentum. The RSI at 46.66 is Neutral, neither overbought nor oversold. The STOCH value of 56.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:GODAVARIB.
Godavari Biorefineries Limited Peers Comparison
Overall Rating
IN:GULPOLY77Outperform
IN:ANDHRSUGAR66Neutral
IN:DEEPAKNTR65Neutral
IN:GODAVARIB55Neutral
IN:SANSTAR54.9Neutral
IN:GEMAROMA42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 77Outperform | INR 10.25B | 6.93 | ― | 0.91% | 9.30% | 425.35% | |
| 66Neutral | INR 10.78B | 10.22 | ― | 1.51% | 16.54% | 204.63% | |
| 65Neutral | INR 217.36B | 20.48 | ― | 0.47% | 25.13% | 99.89% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 10.50B | 39.53 | ― | ― | 7.05% | 26.42% | |
| 55Neutral | INR 19.98B | 37.41 | ― | ― | 4.81% | 142.11% | |
| 42Neutral | INR 7.34B | -38.89 | ― | ― | -17.65% | -147.22% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:GODAVARIB | Godavari Biorefineries Limited | 205.20 | -50.10 | -19.62% | |
| IN:ANDHRSUGAR | Andhra Sugars Limited | 79.55 | 1.49 | 1.92% | |
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1593.65 | -102.70 | -6.05% | |
| IN:GULPOLY | Gulshan Polyols Limited | 164.35 | 16.36 | 11.05% | |
| IN:SANSTAR | Sanstar Limited | 99.78 | 6.84 | 7.36% | |
| IN:GEMAROMA | Gem Aromatics Limited | 140.50 | -39.70 | -22.03% |
Godavari Biorefineries Limited Corporate Events
Godavari Biorefineries Wins Mexican Patent for Antiviral Treatment Compounds
Godavari Biorefineries Limited has secured a patent from the Mexican Patent Office for its invention titled “USE OF COMPOUNDS FOR TREATING VIRAL INFECTIONS.” The patent covers compounds that inhibit V-ATPase activity in cells and their application in...
Godavari Biorefineries faces Rs. 18 crore GST demand after Karnataka tax show cause notice
Godavari Biorefineries Limited has disclosed that it received a show cause notice from the Office of the Commercial Tax Officer (Enforcement), DGSTO, Jamkhandi, Karnataka, concerning alleged short payment, non-payment and ineligible input tax credit...
Godavari Biorefineries Faces ₹17 Crore GST Demand Over ENA Supplies
Godavari Biorefineries Limited has disclosed that it received a show cause notice from the Assistant Commissioner of Central GST, Audit, Belagavi, Karnataka, alleging non-payment of GST on the supply of extra neutral alcohol (ENA) for the period from...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 24, 2026
